News & Blog

Tag Archives: FDA

Survey Results: Clinical Trial Participation

  National Brain Tumor Society, in conjunction with neuro-oncologists, scientific researchers, and the biopharmaceutical industry, is constantly looking for new and better treatments for patients. However, scientific progress in a laboratory does not necessarily always lead to new treatments for patients. First, those laboratory results need to be evaluated and confirmed in high quality clinical trials to ensure […]

Cancer Research Takes the National Spotlight This Week

Two announcements this week thrust the importance of funding biomedical research into the national spotlight, yet again. This Wednesday, Vice President Joe Biden stepped in front of a podium in the White House Rose Garden and made a long anticipated announcement: his decision regarding a presidential bid. However, after the Vice President revealed his plan […]

Brain Tumor Groups Come Together for New Imaging Effort

When an athlete injures their knee, ankle, shoulder, etc. they will often need to go for an “MRI” to determine the extent of the damage done to the affected area. And in most cases the MRI will be able to diagnose the issues with relative ease, accuracy and expediency. Most Americans are familiar with MRIs […]

Share